Alpha Signal Monitor - Daily Market Briefing | April 17, 2026
Daily Market Research Report
April 17, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional Gold ETF Outlook — April 17, 2026
Trading Idea: Buy Rationale (TL;DR): Most top research houses project further upside in gold through 2026, with price targets clustering around $5,000–$6,200/oz (GS $5,400 end‑2026; JPM $5,055 in Q4‑2026; UBS $6,200 for Q1–Q3 2026, $5,900 end‑year; BofA $5,000 with ~$4,400 average; HSBC upside to $5,000 H1‑2026). Drivers cited include ongoing central‑bank buying, renewed ETF inflows, easing real rates, and persistent geopolitical/fiscal risks. (bloomberg.com)
Gold set successive record highs in January 2026 amid a surge in investment and official‑sector demand, a softer USD, and elevated policy/geopolitical uncertainty; UBS CIO subsequently raised 2026 targets and remains long. JPMorgan’s commodities team also highlights robust investor participation and ETF inflows into 2026 as the Fed enters a cutting cycle. (ubs.com)
Key Drivers - Persistent official‑sector (central bank) purchases and strong investment demand underpin prices at elevated levels. (ubs.com) - Renewed ETF inflows expected in 2026 (JPM estimates ~250 tonnes), adding incremental price support alongside bar/coin demand. (jpmorgan.com) - Easing real rates amid an expected Fed cutting cycle improves the relative appeal of non‑yielding assets like gold. (mining.com) - Geopolitical and policy risks (trade tensions, fiscal deficits, institutional uncertainty) continue to motivate portfolio hedging into bullion. (bloomberg.com) - Record‑setting 2025 investment flows (including ETFs) created momentum that has persisted into 2026. (gold.org)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | $5,400/oz (Dec‑2026 target) | Raised end‑2026 target from $4,900 to $5,400, citing sustained private‑sector diversification on top of strong central‑bank and ETF demand; upside risks noted. | 2026-01-22 | https://www.bloomberg.com/news/articles/2026-01-22/goldman-sachs-raises-year-end-gold-forecast-to-5-400-an-ounce |
| Morgan Stanley | Positive | $4,400/oz (2026 forecast) | MS Research revised 2026 gold forecast up from ~$3,313 to $4,400 on weaker USD, ETF inflows and ongoing central‑bank buying. | 2025-10-22 | https://www.morganstanley.com/insights/articles/gold-price-forecast-rally-into-2026 |
| JP Morgan | Bullish | $5,055/oz (Q4‑2026) | Gold remains highest‑conviction long; upside seen as Fed enters cutting cycle; forecast assumes strong investor and official‑sector demand. | 2025-10-24 | https://www.mining.com/gold-price-could-reach-5055-by-q4-2026-says-jpmorgan/ |
| Bank of America | Bullish | Peak ~$5,000/oz in 2026; ~$4,400 average | BofA lifted 2026 outlook citing weaker USD, fiscal deficits and robust investment demand; warns of interim volatility. | 2025-10-13 | https://www.investing.com/news/stock-market-news/bofa-lifts-2026-gold-forecast-to-5000oz-sees-silver-at-65-4283624 |
| Citigroup | Neutral/Cautious | Near‑term (0–3m) target $5,000/oz; expects risk drivers to fade later in 2026 | Citi highlighted that overlapping geopolitical/economic risks support allocations now but sees about half of those risks fading later in 2026; earlier set a 0–3m target at $5,000. | 2026-01-30 | https://www.investing.com/news/stock-market-news/citi-sees-gold-supported-by-risks-with-some-fading-expected-later-in-2026-4477026 |
| UBS | Attractive/Long | $6,200/oz (Mar–Sep 2026); $5,900 end‑2026 | CIO raised targets and maintains a long; drivers include strong central‑bank buying, higher ETF inflows, and bar/coin demand amid lower real rates and USD weakness; scenario range $4,600–$7,200. | 2026-01-29 | https://www.ubs.com/global/en/wealthmanagement/insights/chief-investment-office/house-view/daily/2026/latest-30012026/jcr_content/root/contentarea/mainpar/toplevelgrid_copy_co/col_1/textimage_copy_copy.2049295996.file/dGV4dD0vY29udGVudC9kYW0vYXNzZXRzL3dtL2dsb2JhbC9jaW8vaG91c2Utdmlldy9kb2N1bWVudC9nb2xkLWVuLTE2NTM3ODQucGRm/gold-en-1653784.pdf |
| HSBC | Positive (peak risk in H1) | Upside to $5,000/oz in H1‑2026; 2026 average trimmed to ~$4,587/oz | Sees prices potentially hitting $5,000 in H1‑2026 on geopolitics and rising debt; trimmed 2026 average on risk of later‑year correction. | 2026-01-08 | https://archive.ph/2026.01.08-104356/https%3A/www.reuters.com/business/gold-could-hit-5000-an-ounce-first-half-2026-says-hsbc-2026-01-08/ |
| Deutsche Bank | Bullish | Sees potential to $6,000/oz in 2026 (updated); previously raised 2026 avg to ~$4,450 | DB flagged scope for $6,000 in 2026 on persistent investment demand alongside central‑bank buying; earlier raised 2026 average to ~$4,450. | 2026-01-27 | https://www.investing.com/news/stock-market-news/factboxdeutsche-bank-sees-gold-climbing-to-6000oz-in-2026-4468265 |
Risk Considerations - A hawkish Fed pivot or a sharp rise in real yields could pressure gold and spark ETF outflows. (ubs.com) - HSBC sees risk of a peak in H1‑2026 with potential for a later‑year correction despite a still‑constructive backdrop. (archive.ph) - Improving global growth/risk sentiment could reduce safe‑haven demand; Citi expects some risk drivers to fade later in 2026. (investing.com) - USD strength or a faster‑than‑expected recovery in jewelry demand elasticity could cap upside near‑term. (morganstanley.com)
Position GLD/IAU/BAR overweight on pullbacks and via staged entries. Institutions’ baselines skew toward $5k–$6k outcomes into late‑2026; we prefer lower‑fee IAU/BAR for long‑horizon core exposure and GLD for liquidity‑sensitive or tactical use. Maintain risk controls given potential late‑year volatility if growth improves and real yields back up. (bloomberg.com)
Stock Ratings — Mega-cap Tech: Street Targets and Ratings Snapshot (as of April 17, 2026)
Pulled from public aggregator pages and recent coverage, below are the latest available target prices, ratings, and update dates from Goldman Sachs (GS), Morgan Stanley (MS), JPMorgan (JPM), Bank of America (BAC), Citigroup (C), and Wells Fargo (WFC) for the requested tickers. Where a bank’s most recent public note did not disclose a price target, the target_price field is null.
AAPL - Apple Inc.
Recent activity includes BAC lifting its target to $325 on Apr 14, 2026; MS reiterated Overweight with a $315 PT on Mar 23, 2026; JPM boosted to $325 on Jan 30, 2026; C trimmed to $315 on Jan 2, 2026; WFC set $300 on Oct 31, 2025; GS reiterated Buy on Mar 2, 2026 (no PT shown). Sources: MarketBeat AAPL forecast page.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-03-02 | Reiterated rating; latest public snippet did not display a price target. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Morgan Stanley | Overweight | 315 | 2026-03-23 | Reiterated Overweight with $315 PT. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| JP Morgan | Overweight | 325 | 2026-01-30 | Boosted target $315 → $325. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Buy | 325 | 2026-04-14 | Boosted target $320 → $325. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Citigroup | Buy | 315 | 2026-01-02 | Reiterated Buy; reduced target $330 → $315. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | 300 | 2025-10-31 | Set target $290 → $300; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Buy, Target Price: 316 - Consensus across these six skews Buy/Overweight; average of available targets ≈ $316.
MSFT - Microsoft Corp.
Cluster of Jan 29, 2026 post-earnings updates: MS trimmed PT to $615 (Overweight), JPM to $550 (Overweight), C to $635 (Buy), WFC to $641 (Outperform). BAC initiated Buy with $500 in Mar 2026. GS reiterated Buy on Feb 9, 2026 without a displayed PT.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-02-09 | Reiterated Buy; PT not shown in public snippet. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Morgan Stanley | Overweight | 615 | 2026-01-29 | Lowered PT $630 → $615; reiterated Overweight. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| JP Morgan | Overweight | 550 | 2026-01-29 | Lowered PT $575 → $550. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Buy | 500 | - | Initiated coverage Buy with $500 PT (date not shown in public snippet). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Buy | 635 | 2026-01-29 | Lowered PT $660 → $635; Buy. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Outperform | 641 | 2026-01-29 | Reiterated Outperform; PT $645 → $641. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: 588.2 - Average of available PTs ≈ $588; ratings cluster at Buy/Overweight/Outperform.
GOOGL - Alphabet Inc.
Active into Apr 2026: C raised to $405 (Apr 14, 2026); WFC cut to $361 (Apr 2, 2026). Earlier: GS raised to $375 (Jan 13, 2026), JPM to $375 (Feb 10, 2026), BAC to $370 (Dec 2, 2025), MS to $330 (Oct 30, 2025).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | 375 | 2026-01-13 | Reiterated Buy; target raised $330 → $375. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Overweight | 330 | 2025-10-30 | Raised PT $270 → $330; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Buy | 375 | 2026-02-10 | Boosted PT $323 → $375. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Bank of America | Buy | 370 | 2025-12-02 | Boosted PT $335 → $370. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | Buy | 405 | 2026-04-14 | Reiterated Buy; raised PT $390 → $405. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Overweight | 361 | 2026-04-02 | Lowered PT $397 → $361; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: 369.3 - All six are Buy/Overweight; average of listed targets ≈ $369.
AMZN - Amazon.com Inc.
Spring 2026 changes: WFC nudged target to $305 (Mar 30, 2026). C lifted to $285 (Mar 25, 2026). MS reiterated Overweight with $300 after trimming (Feb 6, 2026). BAC cut to $286 (Jan 21, 2026). GS reiterated Buy on Apr 13, 2026 (no PT displayed). JPMorgan latest not found on the public page.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-04-13 | Reiterated Buy; target not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | 300 | 2026-02-06 | Reiterated Overweight; trimmed PT $315 → $300. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | - | - | - | No recent, target-bearing entry visible on the public aggregator page. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | 286 | 2026-01-21 | Lowered PT $303 → $286. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | Buy | 285 | 2026-03-25 | Raised PT $265 → $285; Buy. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Overweight | 305 | 2026-03-30 | Boosted PT $304 → $305; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: 294 - Average of available PTs (MS/BAC/C/WFC) ≈ $294; ratings skew Buy/Overweight.
NVDA - NVIDIA Corp.
Late Feb 2026 wave: GS raised to $300 (Feb 25), BAC raised to $300 (Feb 25), JPM to $265 (Feb 26), MS set $260 (Feb 27). C initiated Buy on Apr 10, 2026 (no PT shown). WFC reiterated Overweight on Nov 28, 2025 (PT not shown).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | 300 | 2026-02-25 | Boosted PT $275 → $300; Buy. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Morgan Stanley | - | 260 | 2026-02-27 | Set target; rating not displayed in snippet. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Overweight | 265 | 2026-02-26 | Raised PT $250 → $265; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Bank of America | Buy | 300 | 2026-02-25 | Raised PT $275 → $300; Buy. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Citigroup | Buy | - | 2026-04-10 | Initiated/updated Buy; PT not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Wells Fargo | Overweight | - | 2025-11-28 | Reiterated Overweight; PT not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
Consensus View - Rating: Buy, Target Price: 281.25 - Average of available PTs (GS/MS/JPM/BAC) ≈ $281; ratings cluster bullish.
META - Meta Platforms Inc.
Early April 2026: MS trimmed PT to $765, reiterated Overweight (Apr 2, 2026). Citi reiterated Outperform (Jan 29, 2026). Historical GS reiteration Buy (Aug 5, 2025). WFC listing present but latest PT not visible in the snippet. BAC/JPM entries not fully shown on the public page.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2025-08-05 | Reiterated Buy; PT not displayed on public snippet. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | Overweight | 765 | 2026-04-02 | Lowered PT $856 → $765; Overweight. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | - | - | - | Coverage listed; latest target not visible in snippet. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | - | - | - | Coverage listed; latest target not visible in snippet. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | Outperform | - | 2026-01-29 | Reiterated Outperform; PT not shown in snippet. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | - | - | - | Coverage listed; latest target not visible on public page. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
Consensus View - Rating: Buy - Ratings trend positive (MS Overweight; C Outperform; GS Buy), but insufficient public targets to compute a reliable six-bank average.
TSLA - Tesla Inc.
Public aggregator pages track frequent changes; however, latest bank-specific target/ratings for the six named institutions were not visible within our browsing budget. Use nulls below as placeholders; we can fill on request.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
AVGO - Broadcom Inc.
Consensus pages indicate numerous recent target lifts, but latest bank-specific entries for the six named institutions need deeper pulls. Placeholders below with sources for follow-up.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
TSM - Taiwan Semiconductor Manufacturing Co. (TSMC)
Not yet compiled for the six named U.S. institutions within this pass; placeholders provided for follow-up.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
Highlights
- AAPL: BAC $325 (Buy, 2026-04-14); JPM $325 (Overweight, 2026-01-30); MS $315 (Overweight, 2026-03-23).
- MSFT: Broad cluster of Jan 29, 2026 trims but still Buy/Overweight across GS/MS/JPM/C/WFC; BAC initiated Buy with $500 PT in March.
- GOOGL: Citi now $405 (Buy, 2026-04-14); GS $375 (Buy, 2026-01-13); WFC $361 (Overweight, 2026-04-02).
- AMZN: WFC $305 (Overweight, 2026-03-30); MS $300 (Overweight, 2026-02-06); BAC $286 (Buy, 2026-01-21).
- NVDA: GS and BAC both $300 (Buy, 2026-02-25); JPM $265 (Overweight, 2026-02-26); MS $260 (2026-02-27).
Notes: Ratings like Overweight/Outperform are normalized to Buy for consensus. Dates are shown in ISO format (YYYY-MM-DD). MarketBeat forecast pages are used as primary public sources for bank-specific entries.
IPO Calendar
Timeframe: April 17, 2026 to May 17, 2026
Following two large-cap industrial/aerospace IPOs that priced on April 15, 2026 (Madison Air Solutions and Arxis), the visible U.S. pipeline for the next month is led by consumer and healthcare issuers. Convenience retail (Yesway) and life sciences/tools (Alamar Biosciences) are marketing terms, a clinical-stage biotech (Kailera Therapeutics) has filed/updated terms, and Pershing Square’s combined offering (PSUS + PS Inc.) remains in the queue with timing dependent on effectiveness and market tone. Expect schedules to remain fluid; dates can move up or slip with volatility, SEC effectiveness, and bookbuilding conditions. (renaissancecapital.com)
Yesway, Inc. (YSWY)
- Expected listing date: April 22, 2026 (expected)
- Price range: $20.00 – $23.00 per share
- Shares offered: 13,953,488 Class A shares (plus a 30‑day option to purchase up to 2,093,023 additional shares)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Morgan Stanley (lead), J.P. Morgan, Goldman Sachs & Co. LLC, Barclays, BMO Capital Markets, KeyBanc Capital Markets, Guggenheim Securities, Raymond James
- Business summary: Yesway is a U.S. convenience-store operator (Yesway and Allsup’s brands) with ~449 stores across nine Midwestern and Southwestern states. Proceeds are expected to support growth and general corporate purposes.
- Notes: Issuer launched its IPO on April 13, 2026; calendar indications point to the week of April 22, 2026 for trading, subject to SEC effectiveness and market conditions. Date could shift.
- Sources: Yesway launches IPO; terms, share count, range, symbol, and bookrunners confirmed. (nasdaq.com), Upcoming calendar indications for Yesway (date/size context). (renaissancecapital.com)
Alamar Biosciences, Inc. (ALMR)
- Expected listing date: TBD (targeting late April 2026, per deal calendars)
- Price range: $15.00 – $17.00 per share
- Shares offered: 9,375,000 shares (30‑day option for up to 1,406,250 additional shares)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan Securities LLC, BofA Securities, Inc., TD Securities (USA) LLC, Leerink Partners LLC, Stifel, Nicolaus & Company, Incorporated
- Business summary: Commercial-stage proteomics tools company developing ultra‑sensitive protein biomarker detection platforms (e.g., NULISA assays and ARGO system) for research and potential future clinical applications.
- Notes: Filed S-1/A on April 13, 2026 setting terms; timing remains subject to effectiveness and market conditions. Some calendars listed April 16–19; as of April 17, no pricing announcement has been posted publicly.
- Sources: Alamar S‑1/A (terms, shares, range, Nasdaq ‘ALMR’, lead underwriters). (sec.gov), Deal calendars reflecting expected timing window. (ifre.com)
Kailera Therapeutics, Inc. (KLRA)
- Expected listing date: TBD (marketing window expected in late April/early May 2026, subject to effectiveness)
- Price range: $14.00 – $16.00 per share
- Shares offered: 33,333,334 shares (30‑day option to purchase up to 5,000,000 additional shares)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan, Jefferies, Leerink Partners, TD Cowen, Evercore ISI, William Blair (lead manager)
- Business summary: Clinical‑stage biopharmaceutical company focused on metabolic and related diseases; proceeds to fund pipeline development, working capital, and general corporate purposes.
- Notes: Amended S‑1 filed April 13, 2026 setting terms; underwriter syndicate named in the prospectus. No formal pricing date yet as of April 17, 2026.
- Sources: Kailera S‑1/A (terms, range, shares, exchange, underwriters). (sec.gov)
Pershing Square USA, Ltd. (closed‑end fund) and Pershing Square Inc. (combined offering)
- Expected listing date: TBD (combined offering timing to be set; marketing disclosures filed March–April 2026)
- Price range: PSUS preliminary prospectus shows $50.00 per PSUS share; PS Inc. pricing to be determined
- Shares offered: Not finalized in public filings as of April 17, 2026 (PSUS and PS Inc. totals to be determined at pricing)
- Exchange: NYSE (PSUS ‘PSUS’; PS Inc. ‘PS’ expected)
- Business summary: Pershing Square plans a combined offering: (i) PSUS, a 1940‑Act registered, non‑diversified closed‑end fund investing in a concentrated portfolio, and (ii) Pershing Square Inc., the management company earning management and performance fees. Investors in PSUS are expected to receive additional PS Inc. shares as part of the combined structure.
- Notes: Filed S‑1 (PS Inc.) and N‑2 (PSUS) with an Issuer Free Writing Prospectus describing the structure. Underwriter lineup, final size and dates have not been publicly finalized; timing is market‑dependent.
- Sources: PSUS N‑2: structure, listing intent (NYSE ‘PSUS’), $50 PSUS share reference. (sec.gov), PS Inc. S‑1 filing (combined offering background). (sec.gov), Issuer Free Writing Prospectus summarizing the combined offering. (sec.gov)
IPO calendars are inherently fluid. Pricing dates, sizes, ranges, underwriter lineups, and even listing venues may change or be withdrawn before pricing. All entries reflect the best available disclosures as of April 17, 2026 (filings, issuer press releases, and reputable IPO trackers). Always confirm final terms from the SEC‑filed final prospectus (Rule 424(b)) and the exchange on the morning of pricing.
Sources
- Stock Ratings: https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
- IPO Calendar: https://www.ifre.com/equities/2412989/ifr-us-ecm-calendar?utm_source=openai, https://www.nasdaq.com/press-release/yesway-announces-launch-initial-public-offering-2026-04-13, https://www.renaissancecapital.com/IPO-Center/Calendar?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/118343/Airflow-products-manufacturer-Madison-Air-Solutions-prices-IPO-at-%2427-the-h?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2002660/000114036126008532/ny20064799x1_n2.htm, https://www.sec.gov/Archives/edgar/data/2026053/000114036126008560/ny20040230x14_s1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2026053/000114036126008624/ny20040230x16_fwp.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2096997/000119312526151904/d113532ds1a.htm, https://www.sec.gov/Archives/edgar/data/2104204/000119312526151891/d39680ds1a.htm?utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-04-17 at 11:34 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI